Condition: Urinary Incontinence · Overactive Bladder Syndrome · Overactive Bladder · Sponsor: Northwestern University
The objective of our multi-center randomized single-blind study is to examine the safety and effect of intra-detrusor OnabotulinumtoxinA injections at the time of holium laser enucleation of the prostate (HoLEP) in men with overactive bladder symptoms with and without urge incontinence.
This description comes directly from the study's public registry record.
Alyssa McDonald · 312-695-8146 · Alyssa.McDonald@northwestern.edu
Allaa Fadl-Alla · 312-695-8146 · Allaa.Fadlalla@northwestern.edu
Always discuss trial participation with your own doctor first.
| Northwestern Medicine | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05878951